A Memorandum of Cooperation (MoU) has been signed by AD Ports Group with Hayat Biotech to support Hayat Biotech’s global logistics and distribution efforts.
The partnership will facilitate Hayat Biotech’s efforts to establish manufacturing centers around the world and provide logistics solutions to serve its international markets, according to a statement.
The agreement includes the transfer of strategic manufacturing supplies to support the construction of Hayat Biotech’s global biopharmaceutical manufacturing facilities.
AD Ports Group said that once the facilities are ready, they will produce a number of vital biopharmaceutical products, including the Hayat-Vax vaccine, the indigenously produced Covid-19 vaccine in the UAE and the Arab world.
As part of the partnership, distribution will be handled by the HOPE Consortium, which operates one of the largest and most integrated pharma supply chains.
Robert Sutton, CEO of the logistics cluster of AD Ports Group, commented, “Capitalising on Abu Dhabi’s strategic position as a global gateway, we are working together to help position the Emirate as a leading global logistics hub for the life sciences sector.”
